Innovator Liability and Brand-Name Pharmaceuticals Kelly E. Jones, a partner at Harris Beach, discusses innovator liability, which is premised on the notion that a brand-name pharmaceutical manufacturer that allegedly produced inadequate labeling on its brand-name drug has a legal duty to warn consumers, even those who ingested the competing generic version, and how this theory has fared in the courts.
http://www.newyorklawjournal.com/PubArticleNY.jsp?id=1202638307503&rss=rss_nylj_columns
